Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.63 +0.06 / +3.82%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.65 +0.02 / +1.23%
Volume: 934.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Revenue and IncomeNet Revenues3.9M6.5M5.5M6.3M
Cost of Goods Sold2.2M3.6M3.3M3.9M
Depreciation And Amortization244.0K249.0K277.0K265.0K
Operating ExpensesGross Income1.5M2.6M1.9M2.2M
General Expenses11.2M13.2M15.1M14.3M
Research And Development6.6M8.8M10.2M10.0M
Total Operating Expenses13.6M17.0M18.7M18.4M
Non-Operating ExpensesOperating Income-9.7M-10.5M-13.2M-12.1M
Interest Expense On Debt4.0K0.000.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-10.2M-13.1M-12.1M
Preferred Dividend0.00-401.0K-1.0M-1.0M
Net Income-9.7M-10.2M-13.1M-12.1M
Shares To Calculate EPSShares To Calculate EPS163.2M177.3M179.1M180.0M
Shares To Calculate EPS Diluted163.2M177.3M179.1M180.0M
Earnings Per ShareEPS-$0.06-$0.06-$0.08-$0.07
EPS Diluted-$0.06-$0.06-$0.08-$0.07

To view my watchlist

Not a member yet?

Sign up now for a free account